HIGH EXPRESSION OF C-MET WITH WIDE TYPE EGFR MUTATION IDENTIFY A DISTINCT SUBSETS INDICATIVE POOR PROGNOSIS IN PATIENTS WITH NSCLC

被引:0
|
作者
Huang, Ling [1 ]
An, She J. [1 ]
Chen, Zhi H. [1 ]
Su, Jian [1 ]
Xie, Zhi [1 ]
Yan, Hong H. [1 ]
Zhang, Xu C. [1 ]
Huang, Ying [1 ]
Chen, Shi L. [1 ]
Guo, Wei B. [1 ]
Wu, Yi-long [1 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Pulm Oncol, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-050
引用
收藏
页码:S470 / S470
页数:1
相关论文
共 50 条
  • [1] c-MET expression potentially contributes to the poor prognosis of rhabdomyosarcoma
    Du, Juan
    Wang, Yuanyuan
    Meng, Lian
    Liu, Yang
    Pang, Yuwen
    Cui, Wenwen
    Zhang, Liang
    Li, Zhenzhen
    Liu, Qianqian
    Shang, Hao
    Liu, Chunxia
    Li, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (08): : 4083 - 4092
  • [2] High levels of c-Met is associated with poor prognosis in glioblastoma
    Petterson, Stine Asferg
    Dahlrot, Rikke Hedegaard
    Hermansen, Simon Kjaer
    Munthe, Sune K. A.
    Gundesen, Michael Tveden
    Wohlleben, Helle
    Rasmussen, Tine
    Beier, Christoph Patrick
    Hansen, Steinbjorn
    Kristensen, Bjarne Winther
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (03) : 517 - 527
  • [3] High levels of c-Met is associated with poor prognosis in glioblastoma
    Stine Asferg Petterson
    Rikke Hedegaard Dahlrot
    Simon Kjær Hermansen
    Sune K. A. Munthe
    Michael Tveden Gundesen
    Helle Wohlleben
    Tine Rasmussen
    Christoph Patrick Beier
    Steinbjørn Hansen
    Bjarne Winther Kristensen
    Journal of Neuro-Oncology, 2015, 122 : 517 - 527
  • [4] High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma
    Jiang, Mei
    Zhang, Hui
    Xiao, He
    Zhang, Zhimin
    Que, Dan
    Luo, Jia
    Li, Jian
    Mao, Bijing
    Chen, Yuanyuan
    Lan, Meilin
    Wang, Ge
    Xiao, Hualiang
    ONCOLOGY LETTERS, 2018, 15 (01) : 931 - 939
  • [5] Overexpression of EGFR and c-MET in Triple Negative Breast Cancer Is Associated with Poor Prognosis
    Witkiewicz, A. K.
    Lipinski, R. L.
    Solomides, C.
    Peiper, S.
    MODERN PATHOLOGY, 2012, 25 : 73A - 73A
  • [6] Overexpression of EGFR and c-MET in Triple Negative Breast Cancer Is Associated with Poor Prognosis
    Witkiewicz, A. K.
    Lipinski, R. L.
    Solomides, C.
    Peiper, S.
    LABORATORY INVESTIGATION, 2012, 92 : 73A - 73A
  • [7] Prognostic value of high c-Met expression in patients with poor prognosis pancreatic adenocarcinoma following surgical resection: Comparison of three c-Met scoring methods and exploration of underlying mechanisms of c-Met overexpression
    Cros, J.
    Neuzillet, C.
    Tijeras-Raballand, A.
    Raffenne, J.
    Bedossa, P.
    Paradis, V.
    Sauvanet, A.
    Bachet, J. B.
    Raymond, E.
    Hammel, P.
    Couvelard, A.
    VIRCHOWS ARCHIV, 2015, 467 : S4 - S4
  • [8] Prognostic value of high c-Met expression in patients with poor prognosis pancreatic adenocarcinoma following surgical resection: comparison of three c-Met scoring methods and exploration of underlying mechanisms of c-Met overexpression
    Neuzillet, Cindy
    Tijeras-Raballand, Annemilai
    Raffenne, Jerome
    de Gramont, Armand
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    Cros, Jerome
    CANCER RESEARCH, 2015, 75
  • [9] Gold nanorod immunoassay to quantify C-Met expression in NSCLC patients selected for anti-EGFR therapy
    Caldwell, Chuck
    Kannan, Raghuraman
    Arthur, Gerald
    Shin, Dmitry
    Ersoy, Ilker
    Hammer, Richard
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S18 - S18
  • [10] Induction of motility, invasion, and proliferation by wild-type EGFR depends on c-Met in NSCLC
    Dulak, Austin M.
    Gubish, Christopher T.
    Siegfried, Jill M.
    CANCER RESEARCH, 2010, 70